Substituted imidazole compounds as KSP inhibitors
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula:
Novartis Vaccines and Diagnostics, Inc.
C C A C C C A C C C A
C07D C07D A61P C07D C07D C07D A61P C07D C07D C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Weibo Sharadha Paul A. Yi Liana M. David Ryan Nathan M. Rustum Paul A. Savithri Kris G. Tinya J. Annette O. Megan C.
Wang Subramanian Renhowe Xia Lagniton Duhl Constantine Brammeier Boyce Barsanti Ramurthy Mendenhall Abrams Walter Phillips